CAS 77502-96-6

4-(Dimethylamino)-α,2-dimethylbenzeneethanamine

Description:

4-(Dimethylamino)-α,2-dimethylbenzeneethanamine, also known by its CAS number 77502-96-6, is an organic compound characterized by its amine functional group and aromatic structure. This compound features a dimethylamino group attached to a benzene ring that is further substituted with two methyl groups and an ethylamine side chain. The presence of the dimethylamino group contributes to its basicity and potential reactivity, making it a candidate for various chemical reactions, including alkylation and acylation. The compound is typically a colorless to pale yellow liquid or solid, depending on its purity and specific conditions. It is soluble in organic solvents and may exhibit moderate solubility in water due to the amine group. As with many amines, it may have a characteristic amine odor. Safety considerations include handling it with care, as it may be irritating to the skin and eyes, and proper storage is essential to prevent degradation or reaction with other substances.

Formula: C₁₂H₂₀N₂

InChI: InChI=1S/C12H20N2/c1-9-7-12(14(3)4)6-5-11(9)8-10(2)13/h5-7,10H,8,13H2,1-4H3

InChI key: InChIKey=HFQMYSHATTXRTC-UHFFFAOYSA-N

SMILES: C(C(C)N)C1=C(C)C=C(N(C)C)C=C1

Synonyms:

• 4-(1-aminopropyl)-N,N,3-trimethylaniline
• 4-(2-aminopropyl)-N,N,3-trimethylaniline
• 4-(2-aminopropyl)-N,N,3-trimethylaniline dihydrochloride
• 4-(Dimethylamino)-alpha,2-dimethylphenethylamine
• 4-(Dimethylamino)-α,2-dimethylbenzeneethanamine
• Amiflamine
• Benzeneethanamine, 4-(dimethylamino)-alpha,2-dimethyl-
• Benzeneethanamine, 4-(dimethylamino)-α,2-dimethyl-
• Fla 336

(±)-Amiflamine

CAS: 77502-96-6

(±)-Amiflamine (2-dimethylphenethylamine) is an inhibitor of reversible MAO-A.

Formula: C₁₂H₂₀N₂

Purity: 97.24%

Color and Shape: Solid

Molecular weight: 192.3

Ref: TM-T8589

4-(2-Aminopropyl)-N,N,3-trimethylaniline

CAS: 77502-96-6

4-(2-Aminopropyl)-N,N,3-trimethylaniline (4APTMA) is a drug that has been shown to be a 5-HT receptor antagonist. It binds to the 5HT1A receptor and inhibits its activity. 4APTMA can be used for the treatment of metabolic disorders such as obesity and bowel disease. The drug has also been shown to have inhibitory properties in animal models of inflammatory bowel disease, which may be due to its ability to block the uptake of serotonin into the brain. br>br> 4APTMA is metabolized by CYP2D6 and CYP3A4 enzymes. It has also been shown that 4APTMA has an irreversible inhibition effect on dopamine uptake in a model system. This means that it prevents use of dopamine by binding to the transporter protein responsible for this action.

Formula: C₁₂H₂₀N₂

Purity: Min. 95%

Molecular weight: 192.3 g/mol

Ref: 3D-CDA50296